National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 4,662 cases where Vaccine is HEPA or HEPAB or HEPATYP and Serious

Government Disclaimer on use of this data



Case Details

This is page 16 out of 467

Result pages: prev   7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25   next


VAERS ID: 180107 (history)  
Form: Version 1.0  
Age:   
Sex: Female  
Location: Maryland  
Vaccinated:2001-10-04
Onset:2002-01-01
   Days after vaccination:89
Submitted: 2002-01-16
   Days after onset:15
Entered: 2002-01-18
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUZONE) / SANOFI PASTEUR - / 1 - / IM
HEPA: HEP A (HAVRIX) / SMITHKLINE BEECHAM - / 1 - / IM
IPV: POLIO VIRUS, INACT. (POLIOVAX) / SANOFI PASTEUR - / 1 - / SC

Administered by: Other       Purchased by: Other
Symptoms: Encephalitis
SMQs:, Noninfectious encephalitis (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: 2002000399

Write-up: Concomitant vaccines were IPOL, Fluzone and one unspecified vaccine. On 04-OCT-2001, the pt received her first injection of Havrix. In January 2002, 3.5 months post immunization, she developed encephalitis which required hospitalization. The reporting physician believed that the encephalitis was not related to Havrix administration. As of 07-JAN-2002, the outcome of the event was unknown.


VAERS ID: 180942 (history)  
Form: Version 1.0  
Age: 47.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2002-01-25
Onset:2002-01-26
   Days after vaccination:1
Submitted: 2002-02-05
   Days after onset:10
Entered: 2002-02-06
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (HAVRIX) / SMITHKLINE BEECHAM - / 1 - / IM

Administered by: Other       Purchased by: Other
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Hepatitis C virus
SMQs:, Liver related investigations, signs and symptoms (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Ambien; Human Insulin; Salbutamol; Flovent; enalapril
Current Illness:
Preexisting Conditions: Diabetes Mellitus; Elevated ALT and AST
Allergies:
Diagnostic Lab Data: Labs on 1/29/02 revealed AST-(in the 500''s) and ALT-614 U/L
CDC Split Type: 20020020031

Write-up: Report 20020020031 describes hepatitis C in a 47 year old male who received hepatitis A vaccine inactivated (Havrix). The vaccinee received an injection of Havrix on 01/25/2002; it was not known if he had received previous injections of Havrix. At the time of immunization, "AST was inthe 400s" and ALT concentration was 528 U/L. the vaccinee was hospitalized on 01/26/2002, one day post-immunization, with a diagnosis of hepatitis C. Laboratory analysis performed on 01/29/2002 revealed AST "in the 500s" and ALT 614 U/L.


VAERS ID: 181929 (history)  
Form: Version 1.0  
Age: 41.0  
Sex: Male  
Location: Alabama  
Vaccinated:2002-02-06
Onset:2002-02-11
   Days after vaccination:5
Submitted: 2002-02-28
   Days after onset:17
Entered: 2002-03-05
   Days after submission:5
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (HAVRIX) / SMITHKLINE BEECHAM 1124L / 1 LA / IM
YF: YELLOW FEVER (YF-VAX) / SANOFI PASTEUR UB102AA / 1 RA / SC

Administered by: Private       Purchased by: Private
Symptoms: CSF test abnormal, Cyst, Haematocrit decreased, Headache, Laboratory test abnormal, Myalgia, Platelet count increased, Pyrexia, Red blood cell count decreased, Red blood cell sedimentation rate increased, Viral infection, White blood cell count increased
SMQs:, Rhabdomyolysis/myopathy (broad), Haematopoietic erythropenia (narrow), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (broad), Eosinophilic pneumonia (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: Hearing loss; multiple ear and mastoid surgeries with tympanoplasty; he is allergic or intolerant of sulfa and Augmentin
Allergies:
Diagnostic Lab Data: LP; WBC-63; 82% mononucl/lymph ? cells; protein-82; glucose-nml; CPK 2 X nml; CT scan of sinuses-small retention cyst noted; Bun-low; WBC-10.9 high; RBC-low; HGB-12.0 low; HCT-36.5% low; Platelets-422 high; ESR-26 high
CDC Split Type:

Write-up: On 2/11/02, the pt had a fever 100.8F and a headache. Saw PCP on 2/16/02 and was given azithromycin for symptoms. No abatement; pt then given Avalox after increase in severity of fever and headache. Admitted on 2/24/02 with fever of 104F to 105F. He also had myalgia. Discharged on 2/28/02. This is most compatible with a viral illness, probable enteroviral disease. However, cannot rule out a relationship to the recent Yellow Fever vaccine. Will discontinue Tamiflu without further evidence to suggest influenza and add doxycycline empirically.


VAERS ID: 182114 (history)  
Form: Version 1.0  
Age: 44.0  
Sex: Female  
Location: Maryland  
Vaccinated:1998-10-05
Onset:1998-10-26
   Days after vaccination:21
Submitted: 2002-03-05
   Days after onset:1226
Entered: 2002-03-08
   Days after submission:3
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ANTH: ANTHRAX (BIOTHRAX) / EMERGENT BIOSOLUTIONS FAV017 / 6 - / SC
HEPA: HEP A (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 2 - / IM

Administered by: Military       Purchased by: Military
Symptoms: Bone disorder, Carpal tunnel syndrome, Congenital foot malformation, Feeling hot, Guillain-Barre syndrome, Infection, Muscle atrophy, Muscular weakness, Neuropathy peripheral, Oedema peripheral, Pain, Paraesthesia, Polyneuropathy
SMQs:, Rhabdomyolysis/myopathy (broad), Cardiac failure (broad), Angioedema (broad), Peripheral neuropathy (narrow), Congenital, familial and genetic disorders (narrow), Guillain-Barre syndrome (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Demyelination (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Zyrtec; Dimetapp
Current Illness: NONE
Preexisting Conditions: Allergic rhinitis; dermatographia; seizure disorder (off medications since 1990); C6-C7 diskectomy 1989; CTS L more than R 1991
Allergies:
Diagnostic Lab Data: MRI lumbar spine-bilateral S1 foraminal stenosis; Somatosensory Evoked Potentials which demonstrated abnormality in the bilateral peripheral lower sensory pathways and an EMG which revealed an L5-S1 radiculopathy and active denervation of bilateral paraspinal muscles at multiple levels. Repeat EMG in 8/99-worsening and consistent with an acute polyradicular process; LP in 10/99-elevated B. Burgdorferi CSF index;
CDC Split Type:

Write-up: The pt developed vague, general foot discomfort/fatigue; pain at metatarsal heads with weight bearing; intermittent lancinating pains in toes; in warm conditions, feet/toes hot and blush; in cooler conditions toes feel "like they are freezing" and ache. Bending over (to vacuum) increases paresthesias/numbness in shins/dorsal feet. Prolonged standing increases fatigue, discomfort and swelling in feet up to ankles. Fasciculations in calves are still precipitated by exertion. Treatment: Foot discomfort and swelling is greatly relieved by foot exercises and leg elevation and swimming. Neurologist assessment: Acute inflammatory polyneuropathy (AIP) or Guillain-Barre temporally associated with influenza and anthrax vaccines; numbness paresthesias and weakness in both feet in L5-S1 distribution bilaterally secondary to residual effects of AIP; autonomic neuropathy secondary to #1 with secondary dependent edema problems; cervical herniated nucleus pulposus (C5-6 HNP) and bilateral carpal tunnel syndrome. Due to the incompatibility of this service member''s medical condition with the demands of operational/remote/overseas environment, it is recommended that she be found unsuitable for such assignment. No prolonged standing, walking, running or jogging. Pt workload should not exceed 10-11 hours per day in order to allow for medical care requirements. She may need time to maintain her swimming program. Continue physical therapy. Allow use of non-confining (soft) footwear as tolerated, continue silicone orthotics with metatarsal bars (Viscoped), avoid further vaccinations unless specifically reviewed by vaccine safety assessment expert. Administer oseltamivir for influenza prophylaxis as indicated. After a LP in 10/99, Lyme neuroborreliosis was considered and she was given a course of Ceftriaxone therapy (2gms IV qd X 30 days). She noted no immediate improvement in her neurologic symptoms. By 8/00, she noted significantly increased weakness and atrophy of the intrinsic muscles of the feet. A repeat MRI in 8/00 showed findings consistent with a diffuse axonal peripheral neuropathy. She now manifests a claw foot-like deformity of the left foot. Update letter: The sensation in the feet/distal lower extremities has improved slightly with improved sensory discrimination. The strength of the foot intrinsic muscle has improved with improved foot function, toe strength and toe coordination. The autonomic neuropathy findings are still evident with shiny skin in the feet/distal lower extremities, vascular hyperreativity and intermittent dysesthesias-but the foot edema no longer seems to be a problem. Pt feels that the improvement in motor strength/function, resolution of the edema problem and control of the dysethesias is a result of a regualar physical therapy program.


VAERS ID: 182228 (history)  
Form: Version 1.0  
Age: 57.0  
Sex: Female  
Location: Maryland  
Vaccinated:2001-10-06
Onset:2001-12-20
   Days after vaccination:75
Submitted: 2002-03-11
   Days after onset:81
Entered: 2002-03-12
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUZONE) / SANOFI PASTEUR U0590AA / UNK LA / IM
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS 693A6 / UNK LA / IM
IPV: POLIO VIRUS, INACT. (POLIOVAX) / SANOFI PASTEUR T1310 / UNK RA / SC
TYP: TYPHOID VI POLYSACCHARIDE (TYPHIM VI) / SANOFI PASTEUR R14072 / UNK RA / IM

Administered by: Unknown       Purchased by: Unknown
Symptoms: Depressed level of consciousness, Encephalitis, Headache, Respiratory distress, Speech disorder
SMQs:, Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Acute central respiratory depression (broad), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (narrow), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Darvocet N; Premarin; Levbid; Soma; Zoloft; Ditropan; colchicine;Bumex; Slow-K; Calcet; Naldolol; Saligen; Prevacid; Ambien; Aldactone; Multi-Vitamin Pack; Zyrtec; Diflucan; Lortab; Imitrex of Opium; Flonase
Current Illness:
Preexisting Conditions: Allergic to Lactose; Septra; Biaxin; Sulfa; Cipro; Miacalcin (headaches); Ceclor; Mycine; Floxin; clindamycin; PCN; Doxycycline; Cephalexin; Surgeries include T & A; deviated septum; ganglion cyst; Cadlwell-LUC; Othognethic (mouth/jaw); hysterectomy with bladder tuck; submandibular gland; Triumph I port-Rt; Calarect (L & R); sinus rebuild; YAG laser (L & R eyes); Port (Triumph I) left chest; viral gastritis with dehydration; interseal; Fx left hip (pinned x 3); colitis; headaches; fibromyalgia & extreme cramping; Behcet''s Syndrome; aphthous ulcers (gastric, vaginal, oral); Shortness of breath; Reynaud''s Disease; Deep vein thrombosis; Diabetes (med induced, ok now); peripheral neuropathy; Cellulitis R leg; RSD both feet; osteomyelitis
Allergies:
Diagnostic Lab Data: Spinal Tap; Blood cultures for numerous bacteria/viruses-all neg
CDC Split Type:

Write-up: Pt complained of headache and respiratory distress and then soon went "coma" per her husband on 12/20/01 and impaired consciousness and speech at the end of February. Final dx: "viral encephalitis".


VAERS ID: 182416 (history)  
Form: Version 1.0  
Age: 81.0  
Sex: Female  
Location: Unknown  
Vaccinated:2002-02-26
Onset:2002-02-27
   Days after vaccination:1
Submitted: 2002-03-13
   Days after onset:14
Entered: 2002-03-14
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS 5242A4 / UNK - / IM
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS 69A6 / UNK - / IM

Administered by: Other       Purchased by: Other
Symptoms: Pneumonia
SMQs:, Eosinophilic pneumonia (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: UNK
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: CXR-showed pulmonary infiltrates
CDC Split Type: A0360728A

Write-up: On 2/26/02, the pt received Engerix-B (lot ENG5242A4) and Havrix (lot VHA69A6). It was not known if she had received previous injections of Engerix-B or Havrix. On 2/27/02, 1 day post vax, the pt was hospitalized with a dx of pneumonia. The reporter indicated that the pt received Havrix (lot VHA69A6); however, this is not a valid lot number.


VAERS ID: 182608 (history)  
Form: Version 1.0  
Age: 12.0  
Sex: Male  
Location: California  
Vaccinated:2002-02-21
Onset:2002-03-06
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2002-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (VAQTA) / MERCK & CO. INC. 1394L / 1 LA / IM
TYP: TYPHOID VI POLYSACCHARIDE (TYPHIM VI) / CONNAUGHT LABORATORIES R0320 / 1 RA / IM

Administered by: Private       Purchased by: Private
Symptoms: Blood sodium decreased, Laboratory test abnormal, Nephrotic syndrome, Oedema, Proteinuria
SMQs:, Acute renal failure (broad), Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (broad), Systemic lupus erythematosus (broad), Hyponatraemia/SIADH (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Chronic kidney disease (broad), Proteinuria (narrow), Tubulointerstitial diseases (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Allergic rhinitis
Allergies:
Diagnostic Lab Data: Albumin-1.8; Calcium-7.6; Sodium-132; BUN-21; UA-notable for 500mg % protein
CDC Split Type:

Write-up: Nephrotic Syndrome-presented with edema from 3/6/02 to 3/9/02. Seen in ER and treated with Prednisone.


VAERS ID: 183258 (history)  
Form: Version 1.0  
Age: 2.5  
Sex: Unknown  
Location: California  
Vaccinated:2001-11-02
Onset:2001-11-02
   Days after vaccination:0
Submitted: 2001-12-10
   Days after onset:38
Entered: 2002-04-09
   Days after submission:119
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS 697A2 / 1 LA / IM
PNC: PNEUMO (PREVNAR) / PFIZER/WYETH 477553 / 1 LA / IM

Administered by: Public       Purchased by: Public
Symptoms: Ascites, Bacterial infection, CSF test abnormal, Cellulitis, Cyanosis, Feeling cold, Gastroenteritis, Haemorrhage, Hypokinesia, Oedema peripheral, Pulmonary congestion, Pulmonary oedema, Purpura, Pyrexia, Skin discolouration, Skin ulcer, Tachycardia, Toxic shock syndrome
SMQs:, Cardiac failure (narrow), Liver related investigations, signs and symptoms (narrow), Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Angioedema (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Toxic-septic shock conditions (narrow), Parkinson-like events (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Noninfectious diarrhoea (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad), Dehydration (broad), Sepsis (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2001-11-05
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data: Blood, CSF and skin scraping from right leg-all positive for group A Beta Hemolytic strept
CDC Split Type: CA010145

Write-up: Per MD, persistent fever, 8 hours post vax. Decreased mobility on 11/4/01. Mosquito bite looking lesion on right lower leg. On 11/5/01, right lower leg discolored and swollen. To ER. On admit to ER, temperature 39.3C, tachycardia and right lower leg cyanotic, purpuric and cold below the knee. Only pulses present in right leg was femoral; others absent. Bleeding profusely from mucous membranes and puncture sites. Rapidly deteriorated and despite very aggressive CPR, reports child expired. Cause of death dx''d as toxic shock syndrome. Per F/U 4/29/02-Pathologic dxs cellulitis on the right lower extremity; petechial rash on the skin of the head, neck, torso and extremities, hospital blood cultures grouwing out beta-hemolytic Streptococcus Group A bacteria, Meningitis due to: Streptococcus pyogenes, Group A, Beta-hemolytic streptococcus; pulmonary congestion and edema; bilateral hydrothraces; ascites; eosinophilic gastroenteritis. COD: Septic Shock and Bacterial Meningitis due to bacteremia due to cellulitis.


VAERS ID: 183314 (history)  
Form: Version 1.0  
Age: 23.0  
Sex: Male  
Location: Georgia  
Vaccinated:2002-04-01
Onset:2002-04-01
   Days after vaccination:0
Submitted: 2002-04-02
   Days after onset:1
Entered: 2002-04-10
   Days after submission:7
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS 708A6 / 1 LA / IM
IPV: POLIO VIRUS, INACT. (POLIOVAX) / SANOFI PASTEUR T1335 / 1 RA / IM
YF: YELLOW FEVER (YF-VAX) / SANOFI PASTEUR UB127AA / 1 RA / SC

Administered by: Military       Purchased by: Military
Symptoms: Dyspnoea, Heart rate increased, Respiratory rate increased, Wheezing
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Asthma/bronchospasm (broad), Neuroleptic malignant syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: NONE
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: At 14:20, vaccines administered and at 14:45 the pt was discharged with drill instructor. At 15:20, had SOB and bilateral wheezing. O2 sat 94%, pulse 118, RR 30. Medicines given were oxygen, Benadryl, epinephrine, Solu-Medrol, albuterol nebulizer (2). Pt with a rash over his arms. Symptoms improve and is transported to a special care unit for overnight observation. Temperature 98.7F.


VAERS ID: 184057 (history)  
Form: Version 1.0  
Age: 53.0  
Sex: Male  
Location: California  
Vaccinated:2002-03-11
Onset:2002-04-01
   Days after vaccination:21
Submitted: 2002-04-12
   Days after onset:10
Entered: 2002-05-01
   Days after submission:19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS 710A4 / 1 LA / IM
IPV: POLIO VIRUS, INACT. (IPOL) / SANOFI PASTEUR T0908 / 1 LA / SC
TYP: TYPHOID LIVE ORAL TY21A (VIVOTIF) / BERNA BIOTECH, LTD. 0160441A / 1 MO / PO

Administered by: Public       Purchased by: Private
Symptoms: Abasia, Anuria, Dyspnoea, Hypoxia, Muscular weakness, Myelitis transverse, Paraplegia, Pneumonia
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Anaphylactic reaction (broad), Asthma/bronchospasm (broad), Peripheral neuropathy (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Dystonia (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Cardiomyopathy (broad), Demyelination (narrow), Eosinophilic pneumonia (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Tumour lysis syndrome (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Dehydration (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? Yes
Previous Vaccinations:
Other Medications: Ranitidine, paroxetine
Current Illness: NONE
Preexisting Conditions: Peptic ulcer dx, gastritis, chronic bronchitis, ETOH dependence, prior diagnosis of pneumonia. Allergy to steroids and oral anethetics.
Allergies:
Diagnostic Lab Data: Many tests were done.
CDC Split Type:

Write-up: Hospitalized with viral pneumonia at the end of 3/02. Home in 1 1/2 days. Became unable to urinate, legs weak and would not hold him up. Was re-admitted to the hospital and is now dx''d with Transverse Myelitis and is paraplegic. In Rehab Unit in a wheelchair. Was treated with steroids and anti-viral antibiotics. Hospital records state he also had fever, atelectasis upper L lobe, dehydration


Result pages: prev   7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=16&VAX[]=HEPA&VAX[]=HEPAB&VAX[]=HEPATYP&SERIOUS=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166